Organigram Affirm Global FY2026 Revenue expected to be more than $255.197M vs $241.360M Est
Organigram Global (NASDAQ:OGI) affirm FY2026 Revenue expected to be more than $255.197M vs $241.360M Est
Organigram said its money from selling products next year will be bigger than people thought—about $255 million instead of $241 million. When a company says it will make more money than expected, that's something to notice about how the business is doing.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.